Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: ...
MedPage Today on MSN
Adverse Event Risks Vary Among Asthma Biologics, FDA Data Show
CHICAGO -- Adverse event risks varied across biologics used by asthma patients, an analysis of data submitted to the FDA ...
For the 7.5 million Americans diagnosed with psoriasis, it can be disheartening to hear that there's no cure. But there are several treatments that can help keep this autoimmune disease under control.
Vikings rookie quarterback J.J. McCarthy's season was deemed over as soon as he suffered a torn meniscus in his first preseason game in August, and now months after undergoing surgery to repair the ...
Please provide your email address to receive an email when new articles are posted on . Practices receive biologics directly and then bill the payer for their use. Advantages include improved ...
SAN DIEGO -- Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III trials showed. Twice-yearly injections cut total nasal polyps score by ...
The approval of Yesintek and Yesintek I.V., biosimilars to Stelara, strengthens Biocon Biologics' presence in North America and expands its immunology portfolio ...
Psoriatic arthritis treatments can vary depending on the range and severity of symptoms that you may experience. When people with psoriatic arthritis begin to experience moderate or severe symptoms ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback